Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
human fibrin (Tisseel) (1 trial)
Lymphedema (Phase 3)
Postoperative Complications (Phase 3)
Vulvar Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (1 total)